EBS vs LOW · rev $1.04B vs P/E 18, rev $86.29B
Emergent Biosolutions Inc (EBS) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
EBS currently screens at market cap $416.4M. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the EBS and LOW stock pages for the full models.
Not investment advice.